remede® System
FDA premarket approval P160039/S005 · decided 2019-12-23
Approval details
- PMA number
- P160039
- Supplement
- S005
- Supplement type
- Normal 180 Day Track
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- remede® System
- Generic name
- Implanted phrenic nerve stimulator for central sleep apnea
- Applicant
- Respicardia
- Date received
- 2019-08-20
- Decision date
- 2019-12-23
- Days to decision
- 125 days
- Decision code
- APPR
- Product code
- PSR
- Advisory committee
- Anesthesiology
- Expedited review
- No
- Location
- Minnetonka, MN
- Statement
- Approval for software changes to the Model 7001 Remede Reports Application and the addition of Respistim LQ/LQS stimulation lead models to the family of respistim L (left) leads.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| RESPIGUIDE DELIVERY SYSTEM (K130378) | Respicardia | 2013-10-17 |